Comendador, Rosalia R.
HRN: 18-18-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
CO-AMOXICLAV 625MG (TAB)
05/05/2023
05/12/2023
PO
625 Mg
Every 12 Hours
T/C UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes